Cargando…
Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent
Elucidating the targets and mechanism of action of natural products is strategically important prior to drug development and assessment of potential clinical applications. In this report, we elucidated the main targets and mechanism of action of the natural product tonantzitlolone (TZL) in clear cel...
Autores principales: | Sourbier, Carole, Scroggins, Bradley T., Mannes, Philip Z., Liao, Pei-Jyun, Siems, Karsten, Wolf, Dietmar, Beutler, John A., Linehan, W. Marston, Neckers, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745775/ https://www.ncbi.nlm.nih.gov/pubmed/26298773 |
Ejemplares similares
-
Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012) -
Regulating the Regulator: Phosphorylation of PKC θ in T Cells
por: Freeley, Michael, et al.
Publicado: (2012) -
The Novel PKCθ from Benchtop to Clinic
por: Hage-Sleiman, Rouba, et al.
Publicado: (2015) -
Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity
por: Ben-Shmuel, Aviad, et al.
Publicado: (2022) -
PKCθ Signals Activation versus Tolerance In Vivo
por: Berg-Brown, Nancy N., et al.
Publicado: (2004)